A New Path to the Sunshine: Reconsidering Physicians\u27 Financial Conflicts

A New Path to the Sunshine: Reconsidering Physicians’ Financial Conflicts Tuesday, October 18th, 202212:00 PM - 1:00 PM Add to Calendar: iCalendar Google Calendar Virtual for non-students, in-person for students. CLE is available for virtual viewers. Register View Webcast 1.0 hour of CLE credit has been approved Event Description The Elena and Miles Zaremski Law Medicine Forum presents A New Path to the Sunshine: Reconsidering Physicians’ Financial Conflicts For decades, legislators, scholars, and practitioners have expressed dismay over financial conflicts of interest between pharmaceutical and medical device manufacturers and the physicians who use their products. Industry now spends hundreds of millions of dollars annually complying with the Sunshine Act—enacted a decade ago to provide patients with insight into whether their physicians’ recommendations may be tainted by payments from manufacturers. Yet despite its goal of providing transparency, few patients know this information exists, and examination of the program reveals its problems run far deeper than lack of publicity. Join Professor Jacob Elberg as he analyzes key questions striking at the heart of the doctor-patient relationship and proposes a new policy aimed at restoring trust in the health care system. Bio:Professor Elberg is the Director of the Center for Health & Pharmaceutical Law at Seton Hall Law School, where he teaches in the areas of Health Law, Health Care Fraud and Abuse, Evidence, and Data Analytics. His areas of interest include corporate crime and compliance, the role of various actors in the enforcement of health care fraud laws and regulations, and criminal justice policy. He was selected as Seton Hall Law School Faculty Teacher of the Year in 2021. Prior to joining Seton Hall Law School, Professor Elberg served for 11 years as an Assistant U.S. Attorney at the U.S. Attorney’s Office for the District of New Jersey. As Chief of the Office’s Health Care & Government Fraud Unit for five years, Professor Elberg led one of the largest and most impactful health care units in the country, supervising a team of 15 AUSAs and directing all of the Office’s criminal and civil investigations and prosecutions of health care fraud offenses, including investigations and prosecutions of fraud against the government and private health insurance plans, illegal kickback schemes, violations of the Federal Food, Drug & Cosmetic Act, and the improper diversion of prescription drugs including opioids, as well as all health care-related actions brought by the Office under the False Claims Act. In addition, Professor Elberg supervised and directed investigations regarding Foreign Corrupt Practices Act violations, as well as fraud against certain other government agencies and programs. Professor Elberg launched the District of New Jersey’s Data Mining Working Group and spearheaded the Office’s efforts to utilize data analytics to identify, investigate, and prosecute health care fraud offenses